Biopharma Analyst Chen, along with Mitchell Epner, Senior Counsel Member of Kudman Trachten Aloe Posner, discuss the COVID patent infringement litigation between ABUS/Genevant/ROIV and MRNA on an Analyst/Industry conference call to be held on April 26 at 1 pm. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABUS:
- Arbutus Biopharma Announces Q1 2024 Financial Update
- Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
- Cantor Fitzgerald biopharma analyst holds analyst/industry conference call
- Biotech Alert: Searches spiking for these stocks today
- Arbutus Biopharma Wins Favorable Ruling Against Moderna